Currently predicting for Thu, 4 Jun 2026

TRVN Prediction Chart

TRVN Predictions History

Latest community submissions for TRVN.
Predictor Target Session Target Price Result Direction Accuracy Score
Erik Alvarez Erik Alvarez @ErikAlvarez.168356
Sep 15, 2020 $2.74 -99.79% $2.13 X 71.06% 1
JS JS Pro
Aug 28, 2020 $1.62 -99.86% $1.79 X 90.50% 1
iHustle84 iHustle84 Pro
Aug 28, 2020 $1.43 -99.87% $1.79 V 79.89% 0
Devin Mai Devin Mai @DevinMai.171343
Aug 28, 2020 $1.57 -99.86% $1.79 X 87.71% 1
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 13, 2020 $2.03 -99.86% $2.37 V 85.65% 0
JS JS Pro
Aug 13, 2020 $2.19 -99.85% $2.37 V 92.41% 0
iHustle84 iHustle84 Pro
Aug 13, 2020 $2.13 -99.86% $2.37 V 89.87% 0
2poJeff 2poJeff Pro
Aug 13, 2020 $2.35 -99.84% $2.37 V 99.16% 3
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 12, 2020 $1.98 -99.86% $2.29 V 86.46% 1
JS JS Pro
Aug 12, 2020 $2.51 -99.82% $2.29 V 90.39% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TRVN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TREVENA
Trevena
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abno...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE